Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
535.00    10.00 (1.90%)
Bid:
531.00
Ask:
535.00
Spread: 4.00 (0.753%)
Market Cap: £307.86m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Board Changes

19 Jun 2025 07:00

RNS Number : 4775N
Mortgage Advice Bureau (Hldgs) PLC
19 June 2025
 

19 June 2025

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Group")

 

Board Changes

 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1.L), a leading technology-driven UK mortgage network and broker, announces the following directorate appointments and executive changes:

 

Ben Thompson, Deputy CEO, to transition to a new strategic role

Ben Thompson, Deputy CEO, will transition into a newly created strategic role, focusing on building new value by optimising MAB's mortgage opportunity and broadening and strengthening its customer proposition. Ben will step down from his current role and leave the Board at the end of this year.

 

Over the past seven years, Ben has been a key member of the Board, playing an instrumental role in the Group's development and success. His leadership and deep market expertise have earned the trust of colleagues, partners and investors alike, and the Board is delighted that he will be steering this exciting part of MAB's future development.

 

Chief Operating Officer appointment

MAB has appointed Yaiza Luengo as Chief Operating Officer and member of the Executive Committee, with effect from 8 September 2025. She is expected to join the Board when Ben Thompson steps down at the end of this year, subject to all necessary approvals. Yaiza brings over 20 years of international experience in financial services, with a strong track record in driving large-scale transformation, revenue leadership and operational restructuring in regulated environments. She has led technology-enabled change across cloud and data architecture, Artificial Intelligence (AI), digital customer experience and enterprise platforms. Her career includes senior executive roles at RBS, Barclays, HSBC, Refinitiv (now part of LSEG), and WiZink Bank.

 

Non-Executive Director appointments

MAB is pleased to announce the following appointments with immediate effect:

· Mandy Donald as Independent Non-Executive Director. Mandy will Chair the Audit Committee and serve on the Remuneration, Nomination and Group Risk Committees.

· Dr Orlando Machado as Independent Non-Executive Director. Orlando will serve on the Remuneration, Audit, Nomination and Group Risk Committees.

 

Mandy brings extensive experience across both complex organisations and early-stage ventures, with a background in strategy as well as financial and risk management. A Chartered Accountant, Mandy currently serves as Non-Executive Director and Chair of Audit & Risk Committees at several companies in the professional services and financial services sectors. Her previous executive career includes 18 years at EY.

 

Orlando is a leading data scientist and AI expert with 30 years' experience turning data into commercial advantage for global enterprises. Formerly Chief Data Officer at the LEGO Group, Head of UK Data Science and Analytics at Tesco's dunnhumby, and Chief Data Scientist at both MoneySuperMarket and Aviva, he now serves as a Non-Executive Director at the University of Cambridge and adviser to Electrify Video Partners. He previously sat on the Board of Neos, a security technology company acquired by Sky in 2021. Orlando holds a PhD in Statistics from the University of Warwick and was awarded DataIQ's 2023 Professor Derek Holder Lifetime Achievement Award.

 

Both appointments are subject to all necessary approvals.

 

Other changes to Non-Executive Director roles

Also, with effect from 18 June 2025:

· Rachel Haworth will become Senior Independent Non-Executive Director, subject to all necessary approvals, in addition to her current role as Chair of the Remuneration Committee.

· Nathan Imlach, previously Senior Independent Non-Executive Director and Chair of the Audit Committee, will step down as a member of the Audit, Remuneration, Nomination and Group Risk Committees and remain on the Board as a non-independent Non-Executive Director.

 

Mike Jones, Non-Executive Chair, said:

"These Board changes are a natural evolution of MAB. The appointment of Yaiza as Chief Operating Officer, a newly created role, is central to delivering on the ambitions outlined by our Executive Team at our Capital Markets Day earlier this year. Yaiza's considerable operational experience, and technology background will provide important leadership as we deliver on our medium-term growth targets. We look forward to welcoming her to the Board at the end of the year.

 

Since joining the Group in 2018, Ben has been a key member of the team that has delivered significant revenue and market share growth at MAB, and although he has chosen to step down from the Board due to personal circumstances, I am delighted that his major contribution to the business will continue in his new strategic role.

 

I am also very pleased to welcome Mandy and Orlando to the Board. Mandy combines deep financial services expertise and significant Board experience in scaling businesses. Orlando brings data science and AI expertise at Board level, both of which are at the forefront of MAB's strategic decision making. These appointments will benefit the Board and wider organisation greatly.

 

Finally, I would like to thank Nathan for his enormous contribution to the Board as Senior Independent Director since our IPO in 2014. His depth of experience and strategic insight remain a valuable asset to the Board, and we look forward to his continued involvement and guidance. Rachel has made a valuable contribution to the Board since joining in May last year, and we are pleased to welcome her to her new role as Senior Independent Non-Executive Director."

 

 

Regulatory disclosures

The following information is provided in accordance with AIM Rule 17 and Schedule Two (g) of the AIM Rules for Companies:

 

Mandy Donald, aged 52 years, currently holds or has held the following directorships and partnerships in the last five years:

 

Current Directorships/Partnerships

 

Liontrust Asset Management plc - Non-Executive Director and Chair of Audit and Risk committee

 

Begbies Traynor Group plc - Non-Executive Director and Chair of Audit committee

 

JP Morgan US Smaller Companies Investment Trust plc - Non-Executive Director and Chair of Audit committee

 

Gowling WLG LLP - Non-Executive Director

 

Punter Southall Group Limited - Non-Executive Director & Chair of the Audit and Risk Committee

 

Past Directorships/Partnerships in the last 5 years

 

Institute of Cancer Research - Trustee & Audit Committee Chair

 

Dr Orlando Antonio Machado, aged 53 years, currently holds or has held the following directorships and partnerships in the last five years:

 

Current Directorships/Partnerships

 

Oxford Cambridge and RSA Examinations - Director

 

Past Directorships/Partnerships in the last 5 years

 

NEOS Ventures Ltd - Director

 

Save for the information above, MAB is aware of no further disclosures required under these provisions in respect of the appointments of Mandy Donald and Dr Orlando Machado.

 

 

Enquiries:

Mortgage Advice Bureau (Holdings) plc

Via Camarco

 

Peter Brodnicki, Chief Executive Officer

Emilie McCarthy, Chief Financial Officer 

Nominated Adviser and Joint Broker

Keefe, Bruyette & Woods, a Stifel Company

Erik Anderson / Nick Harland / Francis North

 

 

+44 (0) 20 7710 7600

Joint Broker

Berenberg

James Felix / Michael Burke / Dan Gee-Summons 

 

 

+44 (0) 20 3207 7800

Joint Broker

Peel Hunt LLP

Andrew Buchanan / Oliver Jackson / Rob Parker

 

+44 (0) 20 7418 8900

Media Enquiries

Camarco

Tom Huddart / Louise Dolan / Letaba Rimell

 

 

mab@camarco.co.uk

Investor Relations

 

Investor.relations@mab.org.uk

 

About MAB:

MAB is one of the UK's leading consumer intermediary brands and specialist networks for mortgage advisers. 

Through its partner firms known as Appointed Representatives (ARs), MAB has approximately 2,000 advisers providing expert advice to customers on a range of mortgage, specialist lending, protection, and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFIFRVITLIE
Date   Source Headline
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding
24th May 20235:16 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
16th May 20232:23 pmRNSPDMR Dealing and Total Voting Rights
28th Apr 20231:53 pmRNSDirectors' Shareholdings and PDMR notification
27th Apr 20234:39 pmRNSNotification of major holdings
20th Apr 20234:29 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 20235:08 pmRNSPDMR dealing and Total Voting Rights
31st Mar 20232:25 pmRNSDirectors' Shareholdings and PDMR notification
28th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
14th Mar 20235:05 pmRNSDirectors' Shareholdings and PDMR notification
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:35 pmRNSNon-Executive Director Board change
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20231:54 pmRNSDirectors' Shareholdings and PDMR notification
24th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20235:06 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
31st Jan 20237:00 amRNSTrading Update
17th Jan 20234:07 pmRNSDirectors' Shareholdings and PDMR notification
3rd Jan 20239:54 amRNSDirector's Shareholdings and PDMR notification
21st Dec 20227:00 amRNSAppointment of Joint Broker
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20221:51 pmRNSDirectors' Shareholdings and PDMR notification
1st Dec 20227:00 amRNSTrading Update
30th Nov 20224:50 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20224:15 pmRNSPDMR dealing notification and Total Voting Rights
7th Nov 20225:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Oct 20221:18 pmRNSDirectors' Shareholdings and PDMR notification
14th Oct 20225:04 pmRNSDirectors' Shareholdings and PDMR notification
6th Oct 20225:16 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSDirectors' Shareholdings and PDMR notification
4th Oct 20224:27 pmRNSHolding(s) in Company
3rd Oct 20225:13 pmRNSTotal Voting Rights
3rd Oct 20225:11 pmRNSHolding(s) in Company
30th Sep 202210:21 amRNSDirectors' Shareholdings and PDMR notification
27th Sep 20227:00 amRNSInterim Results
16th Sep 202210:36 amRNSDirectors' Shareholdings and PDMR notification
31st Aug 202212:53 pmRNSDirectors' Shareholdings and PDMR notification
16th Aug 202210:27 amRNSDirector/PDMR Shareholding
8th Aug 20224:36 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20221:03 pmRNSPDMR dealing notification and Total Voting Rights
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn
28th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTrading Update
14th Jul 20225:31 pmRNSDirector/PDMR Shareholding
14th Jul 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.